ATC
GraniteShares Autocallable COIN ETF
$20.94
$-0.58 (-2.68%)
Delayed ≥20 min · Aug 13, 2026
Key Statistics
Net Assets (AUM)
$4.08B
Expense Ratio
See prospectus
Previous Close
$21.52
Day Range
$20.94 – $20.94
52-Week Range
$19.96 – $25.11
Volume
80
Avg Vol (50D)
-
Beta
-3.83
Historical Performance
1M
-1.96%
3M
-5.88%
6M
+0.59%
YTD
+0.59%
1Y
+0.59%
3Y
+0.59%
5Y
-2.38%
Total return including reinvested distributions, from adjusted closing prices.
Price History
Price history is being compiled for this fund.
Top Holdings
Detailed holdings are compiled from each fund’s latest SEC N-PORT portfolio filing.
About ATC
Atotech Ltd
ATC News
- GraniteShares Announces Monthly Distributions for its Autocallable ETFs: ANV, TLA, MSR, ATC, PLA, AHD, SCA and MRA
- Why Is ECS Botanics (ASX:ECS) Stirring ASX Penny Stocks Interest?
- Why Is ECS Botanics (ASX:ECS) Driving Fresh Interest in ASX Penny Stocks?
- GraniteShares Announces Monthly Distributions for its Autocallable ETFs: ANV, TLA, MSR, ATC, PLA, AHD, SCA and MRA
- Altech Batteries (ASX:ATC) Secures German Grant Deadline Extension for CERENERGY Project
- FireFly Metals (ASX:FFM) Strengthens Green Bay Story as Junior Miners Stay Active
- Altech Batteries Extends CERENERGY Grant Deadline Following WA Land Sale
- Altech Batteries (ASX:ATC) Sells Non-Core Meckering Land, Raises AUD 950,000
- Bridge to Life Announces Oral Presentations at the 2026 Annual Meeting of the American Transplant Congress (ATC) in Boston, MA, June 20-24, 2026
- GraniteShares Announces Monthly Distributions for its Autocallable ETFs: ANV, TLA, MSR, ATC, PLA, AHD, SCA and MRA
- Hansa Biopharma Announces Late-Breaking Abstract from ConfIdeS Phase 3 Trial Selected for Oral Presentation at ATC 2026
- Hansa Biopharma Announces Late-Breaking Abstract from ConfIdeS Phase 3 Trial Selected for Oral Presentation at ATC 2026
Data for ATC is aggregated from third-party providers (Tiingo, Nasdaq, Finnhub) and SEC filings, may be delayed at least 20 minutes, and may be incomplete or contain errors. Nothing here is investment advice. Verify with the official prospectus before investing.